1. Home
  2. CPIX vs RDZN Comparison

CPIX vs RDZN Comparison

Compare CPIX & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • RDZN
  • Stock Information
  • Founded
  • CPIX 1999
  • RDZN 2015
  • Country
  • CPIX United States
  • RDZN United States
  • Employees
  • CPIX N/A
  • RDZN N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • RDZN Blank Checks
  • Sector
  • CPIX Health Care
  • RDZN Finance
  • Exchange
  • CPIX Nasdaq
  • RDZN Nasdaq
  • Market Cap
  • CPIX 68.7M
  • RDZN 79.4M
  • IPO Year
  • CPIX 2009
  • RDZN N/A
  • Fundamental
  • Price
  • CPIX $4.73
  • RDZN $0.99
  • Analyst Decision
  • CPIX
  • RDZN Strong Buy
  • Analyst Count
  • CPIX 0
  • RDZN 2
  • Target Price
  • CPIX N/A
  • RDZN $5.00
  • AVG Volume (30 Days)
  • CPIX 44.3K
  • RDZN 304.8K
  • Earning Date
  • CPIX 08-05-2025
  • RDZN 08-12-2025
  • Dividend Yield
  • CPIX N/A
  • RDZN N/A
  • EPS Growth
  • CPIX N/A
  • RDZN N/A
  • EPS
  • CPIX N/A
  • RDZN N/A
  • Revenue
  • CPIX $41,083,299.00
  • RDZN $42,893,256.00
  • Revenue This Year
  • CPIX N/A
  • RDZN $4.52
  • Revenue Next Year
  • CPIX N/A
  • RDZN $53.72
  • P/E Ratio
  • CPIX N/A
  • RDZN N/A
  • Revenue Growth
  • CPIX 5.82
  • RDZN 2.79
  • 52 Week Low
  • CPIX $1.04
  • RDZN $0.68
  • 52 Week High
  • CPIX $7.25
  • RDZN $3.28
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 50.35
  • RDZN 51.79
  • Support Level
  • CPIX $5.11
  • RDZN $0.89
  • Resistance Level
  • CPIX $5.88
  • RDZN $1.20
  • Average True Range (ATR)
  • CPIX 0.41
  • RDZN 0.12
  • MACD
  • CPIX -0.05
  • RDZN 0.00
  • Stochastic Oscillator
  • CPIX 37.67
  • RDZN 49.29

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About RDZN Roadzen Inc.

Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.

Share on Social Networks: